Miniaturized and multiplexed high-content screening of drug and immune sensitivity in a multichambered microwell chip

Cell Rep Methods. 2022 Jul 18;2(7):100256. doi: 10.1016/j.crmeth.2022.100256.

Abstract

Here, we present a methodology based on multiplexed fluorescence screening of two- or three-dimensional cell cultures in a newly designed multichambered microwell chip, allowing direct assessment of drug or immune cell cytotoxic efficacy. We establish a framework for cell culture, formation of tumor spheroids, fluorescence labeling, and imaging of fixed or live cells at various magnifications directly in the chip together with data analysis and interpretation. The methodology is demonstrated by drug cytotoxicity screening using ovarian and non-small cell lung cancer cells and by cellular cytotoxicity screening targeting tumor spheroids of renal carcinoma and ovarian carcinoma with natural killer cells from healthy donors. The miniaturized format allowing long-term cell culture, efficient screening, and high-quality imaging of small sample volumes makes this methodology promising for individualized cytotoxicity tests for precision medicine.

Keywords: cell therapy; combinatorial drug therapy; drug screening; immunotherapy; microwell; natural killer cells; precision medicine; tumor on a chip; tumor spheroids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents*
  • Carcinoma, Non-Small-Cell Lung*
  • Cell Culture Techniques
  • Humans
  • Lung Neoplasms*
  • Spheroids, Cellular

Substances

  • Antineoplastic Agents